Back to Search
SEEMA BADVE, MD
MD
Internal Medicine Physician
NPI: 1477533602IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
00026787(AL)19919(MS)
Family Medicine Physician
Family Medicine
Code: 207Q00000X
00026787(AL)
Hospitalist Physician
Hospitalist
Code: 208M00000X
00026787(AL)
Education
OTHER
Class of 1993
Research & Publications (20)
Breast cancer stem cells and intrinsic subtypes: controversies rage on.
PMID 19149630·Curr Stem Cell Res Ther·2009
6-review
Equivalency of RT-PCR and immunohistochemistry: fact or factoid.
PMID 18787946·Breast Cancer Res Treat·2009
6-review
The EP1 subtype of prostaglandin E2 receptor: role in keratinocyte differentiation and expression in non-melanoma skin cancer.
PMID 19625175·Prostaglandins Leukot Essent Fatty Acids·2009
7-preclinical
Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.
PMID 18794199·J Clin Pathol·2009
6-review
Differential gene expression profiling of esophageal adenocarcinoma.
PMID 19327504·J Thorac Cardiovasc Surg·2009
8-other
COX-2 expression does not correlate with microvessel density in breast cancer.
PMID 19188749·Pathobiology·2009
8-other
Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo.
PMID 19564027·J Surg Res·2009
7-preclinical
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.
PMID 18931614·Appl Immunohistochem Mol Morphol·2008
6-review
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover.
PMID 17893231·Carcinogenesis·2008
7-preclinical
Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
PMID 18815242·Clin J Am Soc Nephrol·2008
4-observational
Re: High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system.
PMID 18813329·Mod Pathol·2008
8-other
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
PMID 18824714·J Clin Oncol·2008
3-trial
AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.
PMID 18838536·Mol Cell Biol·2008
8-other
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
PMID 18678838·J Clin Oncol·2008
3-trial
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
PMID 18037662·J Clin Pathol·2008
8-other
Leiomyosarcoma of the penis presenting as a cutaneous lesion.
PMID 18005170·J Cutan Pathol·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8006 HIGHWAY 613
MOSS POINT, MS 39562 - Phone
- (228) 475-1166
Quick Facts
- NPI
- 1477533602
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile